BiomedicalPublications

Antibodies

Multidisciplinary Digital Publishing Institute·Switzerland·ISSN 2073-4468

Open accessIn DOAJFee waivers availableMedicine

Cost to publish

$2,172

Open-access article processing charge, list price.

Time to publication

6 wks

Fast for a peer-reviewed journal — check what review depth that implies.

h-index

57

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

3.1

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Antibodies is listed at $2,172. The publisher also lists 1,800 CHF. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Antibodies, as recorded by OpenAlex for each year. The fee has risen 114% since 2019, from $1,013 to $2,172.

$0$1.1k$2.2k2019: $1,01320192020: $1,05620202021: $1,51220212022: $1,67520222023: $1,77920232024: $2,04620242025: $2,1722025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY
Author keeps copyrightYes
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects Antibodies publishes most, derived from the topics assigned to its indexed articles.

Monoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins ResearchProtein purification and stabilityCAR-T cell therapy researchT-cell and B-cell ImmunologySARS-CoV-2 and COVID-19 ResearchHER2/EGFR in Cancer ResearchImmunotherapy and Immune ResponsesImmune Cell Function and InteractionViral Infectious Diseases and Gene Expression in Insects

Publication record

Indexed articles868
Total citations15,829
i10-index351
Most recent indexed article2026
Open access since2012
All ISSNs2073-4468

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.